tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Esperion Therapeutics Inc

ESPR
Add to Watchlist
3.180USD
0.0000.00%
Close 07-10 16:00（ET）Quotes delayed by 15 min
819.46MMarket Cap
LossP/E TTM

Esperion Therapeutics Inc

3.180
0.0000.00%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

ESPR Financials

See Esperion Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Esperion Therapeutics Inc Earnings Date

Latest Release
May 9, 2026
EPS / Forecast
-0.10/-0.03
Revenue / Forecast
80.10M/84.52M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
403.13M
21.31%
EPS(YoY)
-0.11
60.53%
Analyst Rating
HOLD
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
51.40%-0.10
339.41%0.26
-3.06%-0.16
80.36%-0.06
-157.21%-0.21
78.24%-0.11
58.92%-0.15
28.24%-0.33
145.82%0.36
33.60%-0.50
---0.37
---0.46
---0.79
---0.75
----
----
----
----
----
----
Revenue
23.25%80.10M
143.73%168.45M
69.10%87.31M
11.58%82.39M
-52.81%65.00M
114.30%69.11M
52.00%51.63M
186.33%73.83M
466.14%137.74M
71.38%32.25M
78.97%33.97M
36.86%25.79M
29.16%24.33M
22.19%18.82M
31.72%18.98M
-53.66%18.84M
136.10%18.84M
59.79%15.40M
275.92%14.41M
-80.84%40.66M
Net Profit
37.72%-25.20M
390.04%61.83M
-6.13%-31.33M
79.45%-12.72M
-166.30%-40.45M
62.16%-21.32M
28.43%-29.52M
-24.01%-61.92M
198.87%61.02M
-1.54%-56.34M
25.16%-41.25M
24.71%-49.94M
-8.79%-61.72M
14.79%-55.49M
20.56%-55.12M
-51.88%-66.32M
37.61%-56.73M
37.67%-65.12M
18.79%-69.39M
-135.04%-43.67M
Net Margin
49.47%-31.45%
219.00%36.71%
37.24%-35.89%
81.58%-15.45%
-240.49%-62.24%
82.34%-30.85%
52.91%-57.18%
56.69%-83.87%
117.46%44.30%
40.75%-174.71%
---121.43%
---193.65%
---253.68%
---294.86%
----
----
----
----
----
----
Gross Margin
10.42%56.84%
32.66%83.46%
-20.76%52.71%
-17.13%65.35%
-44.46%51.48%
-2.44%62.91%
9.73%66.52%
7.02%78.86%
77.88%92.69%
-17.21%64.49%
--60.62%
--73.68%
--52.11%
--77.89%
----
----
----
----
----
----
Debt to assets ratio
29.42%117.02%
37.67%117.03%
96.21%164.23%
15.33%85.92%
28.73%90.42%
-33.12%85.01%
-29.07%83.70%
-32.96%74.50%
-32.05%70.24%
21.26%127.11%
--118.01%
--111.13%
--103.37%
--104.82%
----
----
----
----
----
----
Income Statement
Revenue
23.25%80.10M
143.73%168.45M
69.10%87.31M
11.58%82.39M
-52.81%65.00M
114.30%69.11M
52.00%51.63M
186.33%73.83M
466.14%137.74M
71.38%32.25M
78.97%33.97M
36.86%25.79M
29.16%24.33M
22.19%18.82M
31.72%18.98M
-53.66%18.84M
136.10%18.84M
59.79%15.40M
275.92%14.41M
-80.84%40.66M
Operating profit
70.22%-6.58M
2028.35%85.23M
37.86%-9.96M
175.11%7.09M
-130.57%-22.10M
89.57%-4.42M
41.79%-16.03M
106.96%2.58M
248.69%72.27M
0.34%-42.37M
33.85%-27.53M
29.25%-37.06M
-13.06%-48.60M
23.58%-42.51M
25.33%-41.62M
-60.99%-52.38M
38.21%-42.99M
41.79%-55.63M
30.80%-55.74M
-125.19%-32.53M
Net Profit
37.72%-25.20M
390.04%61.83M
-6.13%-31.33M
79.45%-12.72M
-166.30%-40.45M
62.16%-21.32M
28.43%-29.52M
-24.01%-61.92M
198.87%61.02M
-1.54%-56.34M
25.16%-41.25M
24.71%-49.94M
-8.79%-61.72M
14.79%-55.49M
20.56%-55.12M
-51.88%-66.32M
37.61%-56.73M
37.67%-65.12M
18.79%-69.39M
-135.04%-43.67M
Balance Sheet
Current assets
44.13%459.46M
36.86%462.57M
17.20%360.46M
-0.73%342.60M
-12.81%318.78M
68.10%338.00M
40.93%307.56M
48.67%345.11M
45.89%365.61M
-18.49%201.06M
-16.64%218.23M
-8.06%232.13M
-13.83%250.60M
-25.01%246.68M
53.39%261.79M
-8.25%252.48M
6.69%290.82M
-4.89%328.97M
-29.71%170.67M
-14.37%275.17M
Total current liabilities
10.85%300.36M
22.16%300.81M
116.45%359.03M
70.41%298.80M
64.71%270.97M
57.62%246.23M
20.45%165.87M
63.60%175.34M
72.29%164.51M
69.24%156.22M
67.23%137.71M
30.26%107.17M
20.74%95.49M
25.84%92.31M
4.92%82.34M
-0.45%82.28M
-19.21%79.08M
-22.02%73.35M
3.34%78.48M
-1.47%82.64M
Total assets
42.74%462.53M
35.50%465.89M
15.89%364.02M
-1.49%347.08M
-13.14%324.03M
67.07%343.82M
41.94%314.11M
50.16%352.32M
48.15%373.06M
-17.00%205.80M
-29.26%221.31M
-22.82%234.63M
-26.55%251.82M
-35.02%247.94M
38.88%312.83M
8.39%303.98M
23.06%342.85M
8.02%381.59M
-10.25%225.26M
-15.10%280.46M
Total liabilities
2.70%770.46M
4.82%767.85M
19.15%815.38M
12.07%780.59M
12.42%750.24M
10.86%732.54M
8.40%684.32M
14.83%696.54M
14.77%667.36M
15.58%660.79M
4.02%631.31M
1.83%606.60M
-1.76%581.48M
-1.18%571.72M
3.23%606.93M
1.87%595.68M
8.01%591.89M
28.74%578.53M
142.95%587.96M
138.82%584.77M
Total equity
27.75%-307.93M
22.32%-301.96M
-21.92%-451.36M
-25.94%-433.51M
-44.82%-426.21M
14.57%-388.72M
9.71%-370.21M
7.46%-344.22M
10.73%-294.30M
-40.53%-454.99M
-39.41%-410.00M
-27.52%-371.98M
-32.37%-329.66M
-64.40%-323.78M
18.91%-294.10M
4.14%-291.70M
7.56%-249.04M
-104.86%-196.94M
-4148.05%-362.70M
-455.96%-304.31M
Cash Flow Statement
Net operating income
-22.51%-27.72M
229.44%45.24M
87.87%-4.29M
-336.11%-31.42M
-142.04%-22.63M
5.68%-34.95M
-82.79%-35.33M
70.89%-7.21M
199.03%53.83M
12.75%-37.06M
54.88%-19.32M
51.02%-24.75M
-39.41%-54.36M
26.40%-42.47M
38.07%-42.83M
-5.57%-50.53M
56.22%-38.99M
15.82%-57.71M
20.19%-69.17M
-134.34%-47.87M
Net investment
---189.00K
--0.00
100.00%0.00
100.00%0.00
100.00%0.00
--0.00
---167.00K
-100.44%-77.00K
-100.29%-73.00K
100.00%0.00
-100.00%0.00
250.00%17.50M
238.11%25.00M
76.64%-11.79M
--33.00M
--5.00M
---18.10M
-298.26%-50.48M
-100.00%0.00
-100.00%0.00
Net financing
316.23%16.22M
-13.81%30.16M
217.34%10.67M
109.49%2.85M
-108.28%-7.50M
682.73%35.00M
-110.92%-9.10M
-3811.12%-30.02M
83.07%90.61M
114.73%4.47M
-109.31%-4.31M
-95.53%809.00K
3546.52%49.49M
-114.23%-30.36M
1166.54%46.29M
-63.13%18.11M
-170.22%-1.44M
25.21%213.41M
128.87%3.66M
1236.77%49.11M

FAQs

What is the total revenue of Esperion Therapeutics Inc?

According to Esperion Therapeutics Inc's FY2025 earnings report, its total revenue reached 403.13M, with a year-on-year change of 332.31M.

What are the current assets of Esperion Therapeutics Inc?

According to Esperion Therapeutics Inc's FY2025 earnings report, its current assets were 462.57M, with a year-on-year change of 36.86.

What are the total assets of Esperion Therapeutics Inc?

According to Esperion Therapeutics Inc's FY2025 earnings report, its total assets of Esperion Therapeutics Inc were 465.89M, with a year-on-year change of 35.50.

What are the total liabilities of Esperion Therapeutics Inc?

According to Esperion Therapeutics Inc's FY2025 earnings report, its total liabilities of Esperion Therapeutics Inc were 767.85M, with a year-on-year change of 4.82.

What is the total equity of Esperion Therapeutics Inc?

According to Esperion Therapeutics Inc's FY2025 earnings report, its total equity of Esperion Therapeutics Inc was -301.96M, with a year-on-year change of 22.32.

What is the net operating income of Esperion Therapeutics Inc?

According to Esperion Therapeutics Inc's FY2025 earnings report, its net operating income of Esperion Therapeutics Inc was 60.27M, with a year-on-year change of 10.79.

What is the net financing of Esperion Therapeutics Inc?

According to Esperion Therapeutics Inc's FY2025 earnings report, its net financing of Esperion Therapeutics Inc was 36.18M, with a year-on-year change of -58.16.

What is the Earnings Per Share (EPS) of Esperion Therapeutics Inc?

According to Esperion Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.11, with a year-on-year change of 60.53.

What is the net income of Esperion Therapeutics Inc?

According to Esperion Therapeutics Inc's FY2025 earnings report, its net income was -22.68M, with a year-on-year change of 56.17.

What is the net margin of Esperion Therapeutics Inc?

According to Esperion Therapeutics Inc's FY2025 earnings report, its net profit margin was -5.63, with a year-on-year change of 63.87.

What is the gross margin of Esperion Therapeutics Inc?

According to Esperion Therapeutics Inc's FY2025 earnings report, its gross margin was 67.95, with a year-on-year change of -14.38.

What is the debt-to-asset ratio of Esperion Therapeutics Inc?

According to Esperion Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 117.03, with a year-on-year change of -31.32.

What is the Return on Assets (ROA) of Esperion Therapeutics Inc?

According to Esperion Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -5.60, with a year-on-year change of 70.25.

What is the operating profit of Esperion Therapeutics Inc?

According to Esperion Therapeutics Inc's FY2025 earnings report, its operating profit was 60.27M, with a year-on-year change of 10.79.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy